MedPath

Multi-centered open-label, observational study of Sitagliptin in West Tokyo Area

Not Applicable
Recruiting
Conditions
Type2 diabetes
Registration Number
JPRN-UMIN000003362
Lead Sponsor
Tama-center Mirai Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Renal dysfunction ;Creatinin equal or more than 2.0 mg/dl

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of HbA1c (%) and body weight.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath